Table 1.
miRNA | Early Phase ≤24 h | Late Phase 24–72 h | Authors | |
---|---|---|---|---|
Upregulated at one or both phases | 17 | up (J) | up (D) | D, J |
134 | up | up | D, J | |
140 | up | up | D, J | |
145 | up | up | D, J | |
206 | up | up | D, J | |
214 | up | up | D, J | |
290 | up | up | D, J | |
320 | up | up | D, J | |
330 | up | up | D, J | |
331 | up | up | D, J | |
292-5p | up (J) | up (D) | D, J | |
324-3p | up | up | D, J | |
324-5p | up | up | D, J | |
422b | up (J) | up (D) | D, J | |
223 | NC | up | D, J, L | |
Mixed at both phases | 7a | down (J) | down (D), up (J) | D, J |
20a | down (J) | up (D) | D, J | |
25 | down (J) | up (D) | D, J | |
138 | up (J) | down (D) | D, J | |
151 | down (J) | up (D) | D, J | |
361 | down (J) | up (D) | D, J | |
Downregulated at one or both phases | 26b | down | down | D, J |
27a | down (J) | down (D, J) | D, J | |
29b | down | down | D, J | |
29c | down | down | D, J | |
30e | down | down | D, J | |
98 | down | down | D, J | |
137 | down (J) | down (D, J) | D, J | |
218 | down (J) | down (D, J) | D, J | |
335 | down (J) | down (D, J) | D, J | |
664 | down (D, J) | down (D) | D, J | |
379 | NC | down | D, J | |
539 | NC | down | D, J |
Table collates microRNA common to at least 2 of 3 preclinical studies to perform transcriptome-wide analysis following focal cerebral ischemia in rat. Final column designates studies in agreement: D(12), J(28), L(39). NC, no change. Note: specific conditions of experimental MCAO differ across studies and likely contribute to variability in transcriptome changes. For example, D and J employed transient ischemia while L employed permanent ischemia. Refer to original manuscripts for detailed descriptions of experimental stroke procedures.